Tag: $Merck

Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal

Merck on Tuesday reported second-quarter revenue that topped expectations on strong sales of its blockbuster cancer drug Keytruda and HPV vaccine Gardasil.

Germany’s Merck flags decline in operating profit of up to 10% in 2023

Germany’s Merck KGaA on Thursday warned that adjusted operating earnings could decline by as much as 10% this year as the outlook for its specialty chemicals business darkened, offsetting an upswing in drug prescriptions.